MARTINSRIED (dpa-AFX) - Medigene AG (MDGEF.PK), a German biotechnology firm, on Thursday reported a rise in revenue for the third quarter of 2023. In addition, the company has maintained its full-year revenue guidance.
For the three-month period, the drug maker posted a revenue of 1.6 million euros, higher than 1.4 million euros registered for the same period last year.
For the full year 2023, Medigene still expects its revenue to be in the range of 5 million euros to 7 million euros.
Copyright(c) 2023 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2023 AFX News
